Cost Analysis and Financial Implications of a Peritoneal Surface Malignancy Program in the USA-Reference-Cited by-同舟云学术

Cost Analysis and Financial Implications of a Peritoneal Surface Malignancy Program in the USA

Published:2023-10-30 Issue:1 Volume:31 Page:630-644
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Abreu Andres A.,Farah Emile,Nix Robert,Kethley Dustin,Coble Collin,Wan Zhihan,Alterio Rodrigo E.,Ngo Fallon,Wadhwa Anupama,Karagkounis Georgios,Salgado Pogacnik Javier,Wang Sam C.,Augustine Mathew,Yopp Adam C.,Zeh Herbert J.,Polanco Patricio M.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-14442-y.pdf

Reference32 articles.

1. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42.

2. Sugarbaker PH. Surgical management of carcinomatosis from colorectal cancer. Clin Colon Rectal Surg. 2005;18(3):190–203.

3. Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol. 2007;14(1):128–133.

4. Chua TC, Martin S, Saxena A, et al. Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg. 2010;251(2):323–9.

5. Hamilton TD, MacNeill AJ, Lim H, Hunink MGM. Cost-effectiveness analysis of cytoreductive surgery and HIPEC compared with systemic chemotherapy in isolated peritoneal carcinomatosis from metastatic colorectal cancer. Ann Surg Oncol. 2019;26(4):1110–7. https://doi.org/10.1245/s10434-018-07111-y.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus Guidelines for the Management of Peritoneal Surface Malignancies: Introduction and Methodology;2024-04-09

2. Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy;Journal of Clinical Medicine;2023-12-27

3. ASO Author Reflections: Decoding the Complexities of Cytoreductive Surgery and HIPEC Procedural Billing: A Potential Blueprint for the Peritoneal Surface Malignancy Surgeon;Annals of Surgical Oncology;2023-11-19